The Best Pharma Stock to Profit from the 'Patent Cliff'
From Latest Articles from StreetAuthority
November 26, 2012 - 5:12pm
Expiringpatents are usually bad news for major pharmaceutical companies, especially if the patents are for popular "blockbuster" medications generating $1 billion or more of annual
Continue reading this article »
Share This Article: